PUBLICATION

Comparative developmental toxicity of a comprehensive suite of polycyclic aromatic hydrocarbons

Authors
Geier, M.C., Chlebowski, A.C., Truong, L., Massey Simonich, S.L., Anderson, K.A., Tanguay, R.L.
ID
ZDB-PUB-171103-5
Date
2017
Source
Archives of toxicology   92(2): 571-586 (Journal)
Registered Authors
Tanguay, Robyn L.
Keywords
AHR, CYP1A, Developmental toxicity, PAH, Zebrafish
MeSH Terms
  • Animals
  • Cytochrome P-450 CYP1A1/metabolism
  • Embryo, Nonmammalian/drug effects*
  • Larva/drug effects
  • Polycyclic Aromatic Hydrocarbons/chemistry
  • Polycyclic Aromatic Hydrocarbons/toxicity*
  • Toxicity Tests
  • Zebrafish
PubMed
29094189 Full text @ Arch. Toxicol.
CTD
29094189
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental contaminants that occur in complex mixtures. Several PAHs are known or suspected mutagens and/or carcinogens, but developmental toxicity data is lacking for PAHs, particularly their oxygenated and nitrated derivatives. Such data are necessary to understand and predict the toxicity of environmental mixtures. 123 PAHs were assessed for morphological and neurobehavioral effects for a range of concentrations between 0.1 and 50 µM, using a high throughput early-life stage zebrafish assay, including 33 parent, 22 nitrated, 17 oxygenated, 19 hydroxylated, 14 methylated, 16 heterocyclic, and 2 aminated PAHs. Additionally, each PAH was evaluated for AHR activation, by assessing CYP1A protein expression using whole animal immunohistochemistry (IHC). Responses to PAHs varied in a structurally dependent manner. High-molecular weight PAHs were significantly more developmentally toxic than the low-molecular weight PAHs, and CYP1A expression was detected in five distinct tissues, including vasculature, liver, skin, neuromasts and yolk.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping